https://fprimecapital.com/blog/behind-the-breakthrough-qa-with-peptone-kamil-tamiola/
Behind the Breakthrough: Q&A with Peptone, Kamil Tamiola - F-Prime Capital
Aug 6, 2025 - Tamiola had an opportunity early in his career to collaborate with researchers studying proteins implicated in progressive neurodegenerative disorders, like...
breakthrough qbehindampkamil
https://fprimecapital.com/blog/behind-the-breakthrough-qa-with-kai-eberhardt-ceo-and-co-founder-of-oviva/
Behind the Breakthrough: Q&A with Kai Eberhardt, CEO and Co-founder of Oviva - F-Prime Capital
Nov 20, 2025 - Kai Eberhardt transformed a personal cancer diagnosis in his twenties into a lifelong commitment to improving patient empowerment and healthcare accessibility....
breakthrough qbehindampkaiceo
https://fprimecapital.com/blog/behind-the-breakthrough-qa-with-emanuele-ostuni-artbio/
Behind the Breakthrough: Q&A with Emanuele Ostuni, ARTBIO - F-Prime Capital
Aug 6, 2025 - Ostuni shares what drew him to ARTBIO, insights into his current role including leadership style, and advises fellow CEOs to connect with each other since they...
breakthrough qbehindampostuni
https://fprimecapital.com/blog/behind-the-breakthrough-qa-with-lyn-baranowski-avalyn-pharma/
Behind the Breakthrough: Q&A with Lyn Baranowski, Avalyn Pharma - F-Prime Capital
Aug 6, 2025 - Lyn Baranowski, CEO of Avalyn Pharma, brings more than two decades of experience serving in a range of diverse leadership positions across biotech, big pharma,...
breakthrough qbehindamplyn